-+ 0.00%
-+ 0.00%
-+ 0.00%

Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $4

Benzinga·12/05/2024 09:48:21
Listen to the news
Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $3.75 to $4.